Mitchell Gold

Mitchell H.
Gold is the founder of Elixis, Inc., founded in 1995, serving as President & Chief Executive Officer from 1995 to 2000.
Dr. Gold was the founder of Alpine Biosciences, Inc., founded in 2012, serving as Chairman from 2012 to 2014.
Dr. Gold was the founder of Alpine Immune Sciences, Inc., founded in 2007, serving as Executive Chairman & Chief Executive Officer from 2015 to 2024.
Dr. Gold is also the founder of Alpine Bioventures, GP, LLC..
Dr. Gold is currently Director at Prostate Cancer Institute, Director at Life Science Washington, Director at the University of Washington, Independent Director at Attovia Therapeutics, Inc. since 2024, Member-Governors Board at Biotechnology Innovation Organization, and Venture Partner at Frazier Management LLC starting in 2025.
Former positions included Executive Chairman & Chief Executive Officer at Alpine Immune Sciences, Inc., Director at SillaJen Biotherapeutics, Inc., Director at Fred Hutchinson Cancer Research Center, Independent Director at Oric Pharmaceuticals, Inc., Director at Dendreon Corp.
from 2012 to 2013, and VP-Business Development, Sales & Marketing at Data Critical Corp.
from 2000 to 2001.
Education includes an undergraduate degree from the University of Wisconsin conferred in 1989 and a doctorate from Rush Medical College conferred in 1993.